News

Short hairpin RNA (shRNA) is useful where long-term gene suppression is required, or where the cells are resistant to other delivery methods. Its use, however, has been limited

The current treatment, an antiemetic drug, comes in tablet form and is just as effective as the oral spray. Hana believes its new medication could be an alternative

Novartis has developed the breakthrough therapy that will allow patients receiving blood transfusions to be administered iron chelation from a drink rather than the current therapy from infusion.

Influenza infects approximately 5-15% of the world’s population in a typical year, resulting in 250,000 to 500,000 deaths, according to the World Health Organization. Additional grants for program

Chrysalin was being developed to accelerate bone healing in the case of wrist fractures. The study was to test the safety and efficacy of the doses of Chrysalin

The findings suggest that managing stress and reducing certain medications prescribed for the elderly could slow down the progression of this devastating disease. In a study with genetically

The FDA’s revised action date for the drug, which is a derivative of the company’s popular Effexor XR, will now be January 22, 2007. The company said that

The DNA technology is being designed to vaccinate against lethal viral outbreaks including avian influenza. The acquisition of this intellectual property enhances the position of Hemispherx Biopharma in

The new studies of this technology will incorporate influenza genes to assess their improved immunity against influenza and other diseases. “While our initial development efforts will focus on